EPISODE · Jan 21, 2026 · 1H 1M
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
from Hematologic Oncology Update
Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.CME information and select publications here.
NOW PLAYING
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
No transcript for this episode yet
Similar Episodes
Apr 10, 2026 ·42m
Mar 28, 2026 ·31m
Mar 13, 2026 ·30m
Mar 1, 2026 ·27m
Feb 28, 2026 ·35m